PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
24.22
-1.13 (-4.46%)
At close: Mar 6, 2026, 4:00 PM EST
24.22
0.00 (0.00%)
After-hours: Mar 6, 2026, 4:00 PM EST
PROCEPT BioRobotics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 308.05 | 224.5 | 136.19 | 75.01 | 34.47 | |
| Revenue Growth (YoY) | 37.22% | 64.84% | 81.55% | 117.60% | 346.72% | |
| Cost of Revenue | 111.83 | 87.4 | 65.14 | 37.93 | 18.61 | |
| Gross Profit | 196.23 | 137.1 | 71.05 | 37.09 | 15.87 | |
| Selling, General & Admin | 228.81 | 171.42 | 131.77 | 88.83 | 51.04 | |
| Research & Development | 71.28 | 62.3 | 48.45 | 28.98 | 18.99 | |
| Operating Expenses | 300.09 | 233.71 | 180.22 | 117.81 | 70.03 | |
| Operating Income | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 | |
| Interest Expense | -3.59 | -4.18 | -4 | -5.18 | -5.81 | |
| Interest & Investment Income | 12.22 | 10.9 | 7.55 | 2.5 | 0.08 | |
| Other Non Operating Income (Expenses) | -0.16 | -1.14 | -0.2 | -0.49 | 0.05 | |
| EBT Excluding Unusual Items | -95.38 | -91.05 | -105.82 | -83.9 | -59.85 | |
| Other Unusual Items | - | - | - | -3.26 | - | |
| Pretax Income | -95.38 | -91.05 | -105.82 | -87.15 | -59.85 | |
| Income Tax Expense | 0.19 | 0.37 | 0.08 | - | - | |
| Net Income | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 | |
| Net Income to Common | -95.57 | -91.41 | -105.9 | -87.15 | -59.85 | |
| Shares Outstanding (Basic) | 56 | 52 | 47 | 44 | 16 | |
| Shares Outstanding (Diluted) | 56 | 52 | 47 | 44 | 16 | |
| Shares Change (YoY) | 6.56% | 10.31% | 6.43% | 169.42% | 349.90% | |
| EPS (Basic) | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 | |
| EPS (Diluted) | -1.72 | -1.75 | -2.24 | -1.96 | -3.63 | |
| Free Cash Flow | -58.34 | -103.62 | -133.21 | -83.04 | -57.93 | |
| Free Cash Flow Per Share | -1.05 | -1.99 | -2.82 | -1.87 | -3.52 | |
| Gross Margin | 63.70% | 61.07% | 52.17% | 49.44% | 46.02% | |
| Operating Margin | -33.72% | -43.04% | -80.16% | -107.61% | -157.12% | |
| Profit Margin | -31.02% | -40.72% | -77.76% | -116.18% | -173.62% | |
| Free Cash Flow Margin | -18.94% | -46.16% | -97.81% | -110.69% | -168.03% | |
| EBITDA | -97.47 | -91.38 | -105.36 | -77.88 | -50.84 | |
| EBITDA Margin | -31.64% | -40.70% | -77.36% | -103.82% | -147.48% | |
| D&A For EBITDA | 6.39 | 5.23 | 3.81 | 2.84 | 3.32 | |
| EBIT | -103.86 | -96.61 | -109.17 | -80.72 | -54.16 | |
| EBIT Margin | -33.71% | -43.04% | -80.16% | -107.61% | -157.12% | |
| Advertising Expenses | 0.6 | 0.5 | 0.3 | 0.1 | 0.1 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.